. Author manuscript; available in PMC: 2021 Jan 7.

Published in final edited form as: J Mol Biomark Diagn. 2020 Jul 27;11(4):https://www.hilarispublisher.com/open-access/serum-mir92a-is-elevated-in-children-and-adults-with-obstructive-sleep-apnea.pdf.

Table 2.

Serum/plasma markers of cardiometabolic disease (N=70).

Variables	Mean ± SD	Range
Insulin (mU/mL)	18.1 ± 19.0	(2.1–110.0)
CRP^*(mg/L)	2.0 ± 1.7	(0.0–9.0)
Glucose (mg/dL)	91.8 ± 16.0	(70.4–156.4)
AST (U/L)	27.0 ± 15.8	(6.0–110.0)
ALT (U/L)	33.5 ± 27.9	(8.0–201.0)
Total Cholesterol (mg/dL)	89.4 ± 34.4	(40.5–210.0)
Triglyceride (mg/dL)	52.7 ± 56.1	(8.8–421.0)
HDL (mg/dL)	22.6 ± 8.2	(12.6–48.4)
LDL^*(mg/dL)	54.0 ± 24.3	(16.0–152.2)
Cholesterol:HDL ratio	1.6 ± 13	(1.6–7.1)
Log2 miR-92a (fold change)	1.6 ± 3.1	(−6.5–8.0)

n=69